Typical NF2 and LTZR1 mutations are retained in an immortalized human schwann cell model of schwannomatosis.


Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
15 Oct 2024
Historique:
received: 19 06 2024
revised: 26 09 2024
accepted: 03 10 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 24 10 2024
Statut: epublish

Résumé

Human SCs play a primary role in SWN, a rare genetic disorder in which patients develop multiple schwannomas. So that, their isolation and immortalization could represent an irreplaceable tool to investigate the disease etiopathology. Although few clones of tumoural SCs have been obtained, unfortunately they present genetic, morphological and biological characteristics that do not fully represent the original cells. Herein we isolated, characterized and immortalized primary SCs from human schwannomas. Our immortalized human SCs present typical

Identifiants

pubmed: 39444403
doi: 10.1016/j.heliyon.2024.e38957
pii: S2405-8440(24)14988-2
pmc: PMC11497399
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e38957

Informations de copyright

© 2024 The Authors. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Valerio Magnaghi reports financial support was provided by the Ministry of University and Research (MUR). Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Valentina Melfi (V)

Dept. of Pharmacological and Biomolecular Science "R. Paoletti" Università degli Studi di Milano, Italy.

Tasnim Mohamed (T)

Dept. of Pharmacological and Biomolecular Science "R. Paoletti" Università degli Studi di Milano, Italy.

Alessandra Colciago (A)

Dept. of Pharmacological and Biomolecular Science "R. Paoletti" Università degli Studi di Milano, Italy.

Alessandra Fasciani (A)

Human Technopole, Milan, Italy.

Raffaele De Francesco (R)

Dept. of Pharmacological and Biomolecular Science "R. Paoletti" Università degli Studi di Milano, Italy.
INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.

Daniela Bettio (D)

Clinical Genetics Unit, Dept. of Women's and Children's Health, University of Padova, Italy.

Cristina Cerqua (C)

Clinical Genetics Unit, Dept. of Women's and Children's Health, University of Padova, Italy.

Francesca Boaretto (F)

Clinical Genetics Unit, Dept. of Women's and Children's Health, University of Padova, Italy.

Elisabetta Basso (E)

Dept. of Neurosurgery, Ospedale Santa Maria della Misericordia, Rovigo, Italy.

Stefano Ferraresi (S)

Dept. of Neurosurgery, Ospedale Santa Maria della Misericordia, Rovigo, Italy.

Marco Montini (M)

Dept. of Experimental and Clinical, Medical Genetics Unit, Biomedical Sciences "Mario Serio," University of Florence, Florence, Italy.

Marica Eoli (M)

Neuro Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Laura Papi (L)

Dept. of Experimental and Clinical, Medical Genetics Unit, Biomedical Sciences "Mario Serio," University of Florence, Florence, Italy.

Eva Trevisson (E)

Clinical Genetics Unit, Dept. of Women's and Children's Health, University of Padova, Italy.

Valerio Magnaghi (V)

Dept. of Pharmacological and Biomolecular Science "R. Paoletti" Università degli Studi di Milano, Italy.

Classifications MeSH